The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism
Open accessAbstract
BACKGROUND: Patients with cystic fibrosis have altered levels of plasma fatty acids. We previously demonstrated that arachidonic acid levels are increased and docosahexaenoic acid levels are decreased in affected tissues from cystic fibrosis-knockout mice. In this study we determined whether humans with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have a similar fatty acid defect in tissues expressing CFTR. METHODS: Fatty acids from nasal- and rectal-biopsy specimens, nasal epithelial scrapings, and plasma were analyzed from 38 subjects with cystic fibrosis and compared with results in 13 obligate heterozygotes, 24 healthy controls, 11 subjects with inflammatory bowel disease, 9 subjects with upper respiratory tract infection, and 16 subjects with asthma. RESULTS: The ratio of arachidonic to docosahexaenoic acid was increased in mucosal and submucosal nasal-biopsy specimens (P<0.001) and rectal-biopsy specimens (P=0.009) from subjects with cystic fibrosis and pancreatic sufficiency and subjects with cystic fibrosis and pancreatic insufficiency, as compared with values in healthy control subjects. In nasal tissue, this change reflected an increase in arachidonic acid levels and a decrease in docosahexaenoic acid levels. In cells from nasal mucosa, the ratio of arachidonic to docosahexaenoic acid was increased in subjects with cystic fibrosis (P<0.001), as compared with healthy controls, with values in obligate heterozygotes intermediate between these two groups (P<0.001). The ratio was not increased in subjects with inflammatory bowel disease. Subjects with asthma and those with upper respiratory tract infection had values intermediate between those in subjects with cystic fibrosis and those in healthy control subjects. CONCLUSIONS: These data indicate that alterations in fatty acids similar to those in cystic fibrosis-knockout mice are present in CFTR-expressing tissue from subjects with cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Willett, W. C., Dietz, W. H., & Colditz, G. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410607 · Cited by 1,143
The diagnosis of cystic fibrosis: A consensus statement
Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,086
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis
Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M., & Braganza, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391001 · Cited by 954
Relation between Mutations of the Cystic Fibrosis Gene and Idiopathic Pancreatitis
Cohn, J. A., Friedman, K. J., Noone, P. G., Knowles, M. R., Silverman, L. M., & Jowell, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391002 · Cited by 928
Nonparametric Statistical Methods, 2nd, Ed.
Borror, C. M. (2001) · Journal of Quality Technology · doi:10.1080/00224065.2001.11980073 · Cited by 874
Metabolism of highly unsaturated n-3 and n-6 fatty acids
Sprecher, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00077-9 · Cited by 868
Cited by
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Self-citationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Turck, D., Braegger, C. P., Colombo, C., Declercq, D., Morton, A., Pancheva, R., Robberecht, E., Stern, M., Strandvik, B., Wolfe, S., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.004 · Cited by 526
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.003 · Cited by 496
Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness
Levy, B. D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., Israel, E., Haley, K. J., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.496 · Cited by 359
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
Resolvins and protectins: mediating solutions to inflammation
Kohli, P., & Levy, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00290.x · Cited by 292
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
Key mechanisms governing resolution of lung inflammation
Robb, C. T., Regan, K. H., Dorward, D. A., & Rossi, A. G. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0560-6 · Cited by 261
Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases
Giudetti, A. M., & Cagnazzo, R. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.09.006 · Cited by 109
Oral DHA supplementation in ΔF508 homozygous cystic fibrosis patients
Van Biervliet, S., Devos, M., Delhaye, T., Van Biervliet, J. P., Robberecht, E., & Christophe, A. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.12.005 · Cited by 58
Metadata
- Authors
- Freedman, S. D., Blanco, P. G., Zaman, M. M., Shea, J. C., Ollero, M., Hopper, I. K., Weed, D. A., Gelrud, A., Regan, M. M., Laposata, M., Alvarez, J. G., & O'Sullivan, B. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-05
- Volume
- 350
- Issue
- 6
- Pages
- 560-569
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1994622879
- Cited by
- 395
- References
- 38
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.